Work

Cancer nanomedicine for therapy: emerging strategies and expanding perspectives

Year: 2026

Type: editorial

Abstract: ![][1] GUEST EDITOR Linqi Shi is a Professor and Ph.D. supervisor at the College of Chemistry (Nankai University, Tianjin, China). A recipient of the National Science Fund for Distinguished Young Scholars in 2006, Professor Shi later led an Innovative Team of the Ministry of

Source: Cancer Biology and Medicine

DOI: 10.20892/j.issn.2095-3941.2026.0254

Author: Linqi Shi

Institutions: Nankai University, State Key Laboratory of Medicinal Chemical Biology

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,500